Latest
Börse Express Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 9538
- Sources here
- 15
- Companies here
- 29
Search results
Stored financial headlines
Active search
9538 matching headlines
Ticker or company: SCMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Thermo Fisher (TMO) Stock May Be 8% Below Fair Value On Microbiology Sale
Thermo Fisher Scientific (TMO) stock has gained 20.7% over the last year and appears modestly undervalued by about 7.6% according to a Discounted Cash Flow (DCF) model, suggesting it's close to its intrinsic value. While a recent sale of its microbiology business and focus …
TMO
main company
Sharemaestro market context
Trend signal started
52 weeks +18.1%
Bank of Nova Scotia ends one cent below its 52-week high, with bank breadth stronger than volume confirmation
BNS added 3.0% for the week and kept its 19-week Trend Signal active, but participation was below its 13-week norm and momentum gauges have cooled from recent levels.
BNS
main company
Sharemaestro market context
Trend signal active
52 weeks +64.4% · Next-week setup positive 60.1%
Q2 Rundown: MSCI (NYSE:MSCI) Vs Other Financial Exchanges & Data Stocks
Q2 Rundown: MSCI (NYSE:MSCI) Vs Other Financial Exchanges & Data Stocks Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at MSCI (NYSE:MSCI) and its peers. Financial exchanges and data providers …
Sharemaestro market context Trend signal ended 52 weeks -9.6% · Next-week setup negative 44.1%Gilead Sciences (GILD): Buy, Sell, or Hold Post Q2 Earnings?
Gilead Sciences (GILD): Buy, Sell, or Hold Post Q2 Earnings? Over the last six months, Gilead Sciences's shares have sunk to $137.77, producing a disappointing 11.3% loss - a stark contrast to the S&P 500's 13.1% gain. This might have investors contemplating their next …
Sharemaestro market context Price above Trend Line 52 weeks +42.5% · Next-week setup positive 55.2%3 Reasons SCHL is Risky and 1 Stock to Buy Instead
3 Reasons SCHL is Risky and 1 Stock to Buy Instead Scholastic has had an impressive run over the past six months as its shares have beaten the S&P 500 by 9.5%. The stock now trades at $41.58, marking a 22.7% gain. This performance …
SCHL
main company
Sharemaestro market context
Trend signal active
52 weeks +67.2% · Next-week setup positive 61.0%
Precision Trading with Invesco Electric Vehicle Metals Commodity Strategy No K-1 Etf (EVMT) Risk Zones
This article provides a detailed analysis of Invesco Electric Vehicle Metals Commodity Strategy No K-1 Etf (EVMT), identifying neutral near- and mid-term readings and potential downside risk. It outlines institutional trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis …
IVZ
main company
Sharemaestro market context
Trend signal active
52 weeks +54.8% · Next-week setup positive 56.2%
Scholastic director Kaya Henderson sells $130,812 in stock
Scholastic Corp. director Kaya Henderson sold 3,250 shares of company stock for $130,812 on August 6, 2026. Following the sale, Henderson beneficially owns 7,113 shares. The transaction occurred amidst Scholastic reporting Q4 earnings that met profit forecasts but missed revenue expectations, with the stock …
SCHL
main company
Sharemaestro market context
Trend signal active
52 weeks +67.2% · Next-week setup positive 61.0%
Banco Bilbao Vizcaya Argentaria (BME:BBVA) Draws Options Attention, Is The Stock Fully Valued?
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Banco Bilbao Vizcaya Argentaria (BME:BBVA) is drawing fresh attention after the September 18, 2026 €25.00 call option showed some of the highest implied …
BBVA
main company
Sharemaestro market context
Trend signal active
52 weeks +57.5% · Next-week setup positive 65.1%
Ascendis Pharma A/S Just Recorded A 104% EPS Beat: Here's What Analysts Are Forecasting Next
Ascendis Pharma A/S reported strong Q2 results, with revenues beating expectations by 2.8% and statutory profit exceeding forecasts by 104%. Analysts have subsequently upgraded their EPS estimates for 2026, though the consensus price target remains unchanged at US$310. The company is expected to continue …
ASND
main company
Sharemaestro market context
Trend signal active
52 weeks +27.9%
How Henry Schein’s Strong Q2 Earnings and Higher 2026 Sales Outlook Will Impact Henry Schein (HSIC) Investors
Henry Schein, Inc. reported strong Q2 2026 earnings with increased sales and net income, leading management to raise its full-year 2026 sales growth guidance to 4.5% to 5.5%. This positive outlook reinforces the company's strategy of shifting towards higher-margin technology and specialty products, despite …
HSIC
main company
Sharemaestro market context
Trend signal active
52 weeks +29.0%
(PLSE) Risk Channels and Responsive Allocation
This article provides an in-depth AI-driven analysis for Pulse Biosciences Inc (NASDAQ: PLSE), highlighting strong sentiment across all horizons and compelling upside potential. It details institutional trading strategies with specific entry zones, targets, and stop losses for position trading, momentum breakout, and risk hedging. …
PLSE
main company
Sharemaestro market context
Trend signal active
52 weeks +161.2%
Will Gilead’s AI-Driven ADC Research with Nucleai Refine Its Oncology Strategy and Valuation Story (GILD)?
Gilead Sciences is partnering with Nucleai for AI-powered tissue analytics to enhance its antibody-drug conjugate (ADC) clinical development and precision oncology efforts. This collaboration supports Gilead's long-term strategy to pivot into oncology, leveraging its strong HIV core business. However, despite the potential of AI-enabled …
GILD
main company
Sharemaestro market context
Price above Trend Line
52 weeks +23.7%
Oppenheimer Asset Management Inc. Makes New Investment in SiteOne Landscape Supply, Inc. $SITE
Oppenheimer Asset Management Inc. has acquired a new position in SiteOne Landscape Supply, Inc. (NYSE:SITE), purchasing 26,740 shares valued at approximately $3.06 million. This investment comes amidst mixed analyst sentiment, with a consensus "Hold" rating despite the company missing recent quarterly earnings and revenue …
SITE
main company
Sharemaestro market context
Price below Trend Line
52 weeks -33.0%
Summit Global Investments Buys New Shares in Gilead Sciences, Inc. $GILD
Summit Global Investments initiated a new position in Gilead Sciences, acquiring 11,712 shares valued at $1.48 million during the second quarter. Gilead Sciences reported strong Q2 earnings, surpassing revenue and EPS expectations, with a 10.6% year-over-year revenue increase and declared a quarterly dividend of …
GILD
main company
Sharemaestro market context
Price above Trend Line
52 weeks +23.7%
Simplify Asset Management Inc. Buys 5,670 Shares of Thermo Fisher Scientific Inc. $TMO
Simplify Asset Management Inc. increased its stake in Thermo Fisher Scientific Inc. (TMO) by 32.6% in the second quarter, purchasing 5,670 additional shares. This brings their total holding to 23,079 shares, valued at approximately $11.6 million. Institutional investors collectively own 89.23% of TMO, with …
TMO
main company
Sharemaestro market context
Trend signal started
52 weeks +18.1%
HM Payson & Co. Sells 20,885 Shares of Thermo Fisher Scientific Inc. $TMO
HM Payson & Co. reduced its stake in Thermo Fisher Scientific Inc. by 11.3%, selling 20,885 shares but still holding 163,790 shares valued at $82.1 million. Despite insider selling of over $30.6 million in the last 90 days, Thermo Fisher reported strong quarterly results …
TMO
main company
Sharemaestro market context
Trend signal started
52 weeks +18.1%
Thermo Fisher Scientific Inc. $TMO Shares Sold by Wedge Capital Management L L P NC
Wedge Capital Management L L P NC significantly reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 93.3% in the second quarter, selling over 11,000 shares. Despite this, other institutional investors either increased or initiated stakes in the company, with institutional ownership remaining …
TMO
main company
Sharemaestro market context
Trend signal started
52 weeks +18.1%
Centric Wealth Management Takes $3.52 Million Position in Gilead Sciences, Inc. $GILD
Centric Wealth Management has acquired a new stake of 26,506 shares in Gilead Sciences, Inc. (NASDAQ:GILD), valued at approximately $3.52 million during the second quarter. This move is part of broader institutional interest, with 83.67% of Gilead's stock owned by institutional investors and hedge …
GILD
main company
Sharemaestro market context
Price above Trend Line
52 weeks +23.7%
GSA Capital Partners LLP Acquires New Position in MSCI Inc $MSCI
GSA Capital Partners LLP has acquired a new position in MSCI Inc. (NYSE:MSCI), purchasing 3,826 shares valued at approximately $2.143 million during the second quarter. This move comes as other institutional investors have also adjusted their stakes in the technology company. MSCI recently announced …
MSCI
main company
Sharemaestro market context
Price below Trend Line
52 weeks +0.1%